COVID-19 & CancerFree COVID-19 vs. community oncology: Flatiron’s data provides first damage assessment May 01, 2020Vol.46 No.18By Matthew Bin Han Ong
Drugs & TargetsFree FDA grants accelerated approval for Trodelvy in previously-treated metastatic TNBC April 24, 2020Vol.46 No.17
Drugs & TargetsFree FDA approves first targeted treatment for patients with cholangiocarcinoma April 24, 2020Vol.46 No.17
Clinical RoundupFree Phase III CheckMate-743 study of Opdivo and Yervoy meets primary OS endpoint in mesothelioma April 24, 2020Vol.46 No.17
Clinical RoundupFree Phase III CheckMate -9ER meets primary PFS endpoint in RCC April 24, 2020Vol.46 No.17
Clinical RoundupFree New targeted agent produces responses in trial with patients with uterine serous carcinoma April 24, 2020Vol.46 No.17
Clinical RoundupFree RVD Therapy shows substantial benefit in large myeloma study April 24, 2020Vol.46 No.17
